Interventional Spine to present at and participate as sponsor of Spine Technology Summit

Interventional Spine, Inc., a privately held medical device manufacturer focusing on diseases of the spine, will present at the Spine Technology Summit at the Roosevelt Hotel in New Orleans on Monday April 26th. This annual event is a showcase for 40 new technology companies and attracts investors, industry, practitioners and analysts.

"Interventional Spine, Inc. is proud to present at and participate as a sponsor of the Spine Technology Summit. The core focus of this meeting is to discuss new patient options that can relieve pain sooner, decrease complications and recovery time, improve quality of life, and reduce the costs associated with back problems. We appreciate the opportunity to showcase our new technologies at industry conferences like the Spine Technology Summit and to participate in a marketplace with many innovative and beneficial opportunities for the patients," said Walter A. Cuevas, Interventional Spine's Chief Executive Officer. He continued by stating, "Presently, the cost of conventional treatment modes have a negative impact in our economy and in our ability as a nation to address unmet medical needs. First-to-market is now also a concept understood by both industry and medicine. Large spine companies have been driven to consolidate around new technologies in order to provide therapies to increasingly Internet-informed patients."

Mr. Cuevas added, "Interventional Spine, Inc. is also sponsoring a luncheon lecture and workshop at the International Society for the Advancement of Spine Surgery (SAS) Meeting in New Orleans on Thursday April 29th at noon. The title of the workshop is: The First and Only Interspinous Allograft Technology for the Treatment of Lumbar Spinal Stenosis (LSS) and The Next Generation Percutaneous Technology for Posterior Stabilization of Anterior Cervical Fusion (ACDF). Here attendees will have a chance to take a look into the future of spine surgery, a future that could bring relief to patients sooner, with less pain and shorter recovery time...and a future that could lower the costs of treatment."